Low Dose Metronomic Gemcitabine has High Antimetastatic Efficacy in an Orthotopic Mouse Model of Pancreatic Cancer

被引：0
|
作者：
Cao, H. S. Tran [1 ]
Bouvet, M. [1 ]
Romney, E. [2 ]
Kaushal, S. [1 ]
Keleman, A. [2 ]
Kim, G. [2 ]
Fruehauf, J. [2 ]
Imagawa, D. K. [2 ]
Hoffman, R. M. [3 ]
Katz, M. H. [2 ]
机构：
[1] UC San Diego, San Diego, CA USA
[2] UC Irvine, Orange, CA USA
[3] Anticancer Inc, San Diego, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model
    Lee, NC
    Bouvet, M
    Nardin, S
    Jiang, P
    Baranov, E
    Rashidi, B
    Yang, M
    Wang, XE
    Moossa, AR
    Hoffman, RM
    CLINICAL & EXPERIMENTAL METASTASIS, 2001, 18 (05) : 379 - 384
  • [2] Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model
    Natalie C. Lee
    Michael Bouvet
    Stephanie Nardin
    Ping Jiang
    Eugene Baranov
    Babak Rashidi
    Meng Yang
    Xiaoen Wang
    A.R. Moossa
    Robert M. Hoffman
    Clinical & Experimental Metastasis, 2000, 18 : 379 - 384
  • [3] Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer
    Graeser, Ralph
    Bornmann, Christian
    Esser, Norbert
    Ziroli, Vittorio
    Jantscheff, Peter
    Unger, Clemens
    Hopt, Ulrich T.
    Schaechtele, Christoph
    von Dobschuetz, Ernst
    Massing, Ulrich
    PANCREAS, 2009, 38 (03) : 330 - 337
  • [4] Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy
    Sugisawa, Norihiko
    Miyake, Kentaro
    Higuchi, Takashi
    Oshiro, Hiromichi
    Zhang, Zhiying
    Park, Jun Ho
    Kawaguchi, Kei
    Chawla, Sant P.
    Bouvet, Michael
    Singh, Shree Ram
    Unno, Michiaki
    Hoffman, Robert M.
    ANTICANCER RESEARCH, 2019, 39 (10) : 5339 - 5344
  • [5] Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model
    Johnson, Jodee L.
    Dia, Vermont P.
    Wallig, Matthew
    de Mejia, Elvira Gonzalez
    PANCREAS, 2015, 44 (01) : 144 - 151
  • [6] Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer
    Cao, Hop S. Tran
    Bouvet, Michael
    Kaushal, Sharmeela
    Keleman, Alex
    Romney, Eric
    Kim, Ginna
    Fruehauf, John
    Imagawa, David K.
    Hoffman, Robert M.
    Katz, Matthew H. G.
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 204 - 204
  • [7] Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
    Cao, Hop S. Tran
    Bouvet, Michael
    Kaushal, Sharmeela
    Keleman, Alex
    Romney, Eric
    Kim, Ginna
    Fruehauf, John
    Imagawa, David K.
    Hoffman, Robert M.
    Katz, Matthew H. G.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 2068 - 2078
  • [8] Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model
    Narayanan, Jayanth S. Shankara
    Vicente, Diego A.
    Ray, Partha
    Chai, Louis F.
    Erdem, Suna
    Carr, Matthew J.
    Capacio, Benedict A.
    Cox, Bryan F.
    Jaroch, David B.
    Katz, Steven C.
    White, Rebekah R.
    SURGERY, 2020, 168 (03) : 448 - 456
  • [9] A new liposomal formulation of gemcitabine is active in an orthotopic mouse model of pancreatic cancer
    Esser, Norbert
    Graeser, Ralph
    Bornmann, Christian
    Ziroli, Vittorio
    Unger, Clemens
    Hopt, Ulrich
    Von Dobschutz, Ernst
    Schaechtele, Christoph
    Massing, Ulli
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Synergistic Therapeutic Efficacy of bi-shRNA Nanoplex Targeting to Mesothelin with Gemcitabine in an Orthotopic Pancreatic Cancer Mouse Model
    Li, D.
    Marian-Muller, C.
    Rao, D. D.
    Jay, C. M.
    Nemunaitis, J.
    Chen, C.
    Yao, Q.
    MOLECULAR THERAPY, 2014, 22 : S207 - S207
12345